4.6 Review

LncRNAs and Esophageal Squamous Cell Carcinoma - Implications for Pathogenesis and Drug Development

Journal

JOURNAL OF CANCER
Volume 7, Issue 10, Pages 1258-1264

Publisher

IVYSPRING INT PUBL
DOI: 10.7150/jca.14869

Keywords

LncRNA; Esophageal Squamous Cell Carcinoma; Pathogenesis; Drug Development

Categories

Funding

  1. National High Technology Research and Development Program of China (863 Program) [2014AA021102]
  2. Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases [2015017]
  3. National Natural Science Foundation of China [61502292]

Ask authors/readers for more resources

LncRNAs are a group of ncRNA species longer than 200 nt, which have fundamental regulatory roles in diverse cellular processes and diseases progression. Esophageal cancer is a serious malignancy with respect to prognosis and mortality rate. It is among the five leading cancer types for the cancer deaths in males of middle age in the United States. In China, esophageal cancer is the fourth most frequently diagnosed cancer and the fourth leading cause of cancer death. The molecular mechanisms of esophageal cancer development are not fully understood, but emerging studies point out that lncRNAs may actively associate with the pathogenesis. In this review, we first provided an introduction of lncRNAs classifications. Then we focused on the recent findings on lncRNA expression and function in esophageal cancer development. Implications for pathogenesis and potential drug developments will also be discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available